Abstract
A high incidence of bladder cancer has been documented in an area of chronic arsenic (As) exposure. This study investigates the characteristics of As-associated (n = 49) and other (n = 64) bladder cancers. A higher histological grading was observed for the As-exposed tumours (P = 0.04), but no other difference in pathobiological features or prognosis was found between the two groups.
Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chen C. J., Chen C. W., Wu M. M., Kuo T. L. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer. 1992 Nov;66(5):888–892. doi: 10.1038/bjc.1992.380. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen C. J., Chuang Y. C., You S. L., Lin T. M., Wu H. Y. A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br J Cancer. 1986 Mar;53(3):399–405. doi: 10.1038/bjc.1986.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen C. J., Wang C. J. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res. 1990 Sep 1;50(17):5470–5474. [PubMed] [Google Scholar]
- Chiang H. S., Guo H. R., Hong C. L., Lin S. M., Lee E. F. The incidence of bladder cancer in the black foot disease endemic area in Taiwan. Br J Urol. 1993 Mar;71(3):274–278. doi: 10.1111/j.1464-410x.1993.tb15942.x. [DOI] [PubMed] [Google Scholar]
- Chiou H. Y., Hsueh Y. M., Liaw K. F., Horng S. F., Chiang M. H., Pu Y. S., Lin J. S., Huang C. H., Chen C. J. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res. 1995 Mar 15;55(6):1296–1300. [PubMed] [Google Scholar]
- Cuzick J., Sasieni P., Evans S. Ingested arsenic, keratoses, and bladder cancer. Am J Epidemiol. 1992 Aug 15;136(4):417–421. doi: 10.1093/oxfordjournals.aje.a116514. [DOI] [PubMed] [Google Scholar]
- Lee S. E., Chow N. H., Chi Y. C., Tzai T. S., Yang W. H., Lin S. N. Expression of c-erbB-2 protein in normal and neoplastic urothelium: lack of adverse prognostic effect in human urinary bladder cancer. Anticancer Res. 1994 May-Jun;14(3B):1317–1324. [PubMed] [Google Scholar]
- Lee T. C., Wang-Wuu S., Huang R. Y., Lee K. C., Jan K. Y. Differential effects of pre- and posttreatment of sodium arsenite on the genotoxicity of methyl methanesulfonate in Chinese hamster ovary cells. Cancer Res. 1986 Apr;46(4 Pt 1):1854–1857. [PubMed] [Google Scholar]
- Rossman T. G., Stone D., Molina M., Troll W. Absence of arsenite mutagenicity in E coli and Chinese hamster cells. Environ Mutagen. 1980;2(3):371–379. doi: 10.1002/em.2860020307. [DOI] [PubMed] [Google Scholar]
- Shibata A., Ohneseit P. F., Tsai Y. C., Spruck C. H., 3rd, Nichols P. W., Chiang H. S., Lai M. K., Jones P. A. Mutational spectrum in the p53 gene in bladder tumors from the endemic area of black foot disease in Taiwan. Carcinogenesis. 1994 Jun;15(6):1085–1087. doi: 10.1093/carcin/15.6.1085. [DOI] [PubMed] [Google Scholar]
- Smith A. H., Hopenhayn-Rich C., Bates M. N., Goeden H. M., Hertz-Picciotto I., Duggan H. M., Wood R., Kosnett M. J., Smith M. T. Cancer risks from arsenic in drinking water. Environ Health Perspect. 1992 Jul;97:259–267. doi: 10.1289/ehp.9297259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tseng W. P. Effects and dose--response relationships of skin cancer and blackfoot disease with arsenic. Environ Health Perspect. 1977 Aug;19:109–119. doi: 10.1289/ehp.7719109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tsuda T., Babazono A., Yamamoto E., Kurumatani N., Mino Y., Ogawa T., Kishi Y., Aoyama H. Ingested arsenic and internal cancer: a historical cohort study followed for 33 years. Am J Epidemiol. 1995 Feb 1;141(3):198–209. doi: 10.1093/oxfordjournals.aje.a117421. [DOI] [PubMed] [Google Scholar]
